North America dominates the Disposable Integrated Membrane Oxygenator market with a 40% share, driven by advanced healthcare infrastructure, high adoption of cutting-edge technologies, and robust R&D investments. The region benefits from mature ECMO (Extracorporeal Membrane Oxygenation) ecosystems and stringent regulatory frameworks ensuring product quality. Additionally, the aging population and rising incidence of respiratory diseases fuel demand. Asia-Pacific is emerging as the fastest-growing region, projected to expand at a CAGR of 12% through 2030. This growth is underpinned by increasing healthcare investments, government initiatives to modernize medical facilities, and a surge in disposable income in countries like India and China. Europe holds a 25% market share, supported by strong reimbursement policies, high awareness of critical care technologies, and a focus on reducing hospital-acquired infections. Meanwhile, Latin America and the Middle East & Africa account for smaller shares (10% and 5%, respectively), but are gaining traction due to public-private partnerships and improving healthcare access in urban centers.